![](/img/cover-not-exists.png)
Development of a closed system process for purifying naive CD8+ cells, culturing and transducing with a CD19/22 chimeric antigen receptor (CAR) to produce a clinical T memory stem cell product directed against B cell malignancies
Fellowes, V., Cai, Y., Rodriguez-Mesa, E., Grandinetti, P., Jin, J., Highfill, S.L., Schneider, D., Dropulic, B., Stroncek, D., Gress, R., Gattinoni, L.Volume:
22
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2020.03.288
Date:
May, 2020
File:
PDF, 182 KB
2020